Address by Prof. Mojisola Christianah Adeyeye Fas, at the SMEDAN-NAFDAC Summit
Address by Prof. Adeyeye C. M Director General NAFDAC SMEDAN-NAFDAC Summit Ecobank Pan African Centre (EPAC) Victoria Island Lagos. 9th November, 2026 Protocol Good Afternoon Ladies and Gentlemen. It is with great pleasure that I address this Distinguished gathering of Micro, Small and Medium Entrepreneurs at this SMEDAN-NAFDAC summit. I want to commend the […]
NAFDAC DG Reaffirms Commitment to Curb Illegal Pesticides, Protect Food Safety and Safeguard Nigeria’s Agricultural Future
The National Agency for Food and Drug Administration and Control (NAFDAC) reaffirmed its commitment to strengthening the regulation of pesticides in Nigeria, curbing the circulation of banned, unregistered and falsified pesticide products, and protecting public health, food safety and the integrity of the nation’s agricultural value chain. NAFDAC’s stronger focus on pesticide control recognizes that […]
Address by Prof. Mojisola Christianah Adeyeye at the 49th Annual International Conference of the Chemical Society of Nigeria
Address by Prof. Adeyeye C. M Director General NAFDAC 49th Annual International Conference of the Chemical Society of Nigeria NAF Conference Centre, Ahmadu Bello Way, Kado, Abuja. 15th September, 2026 Theme: “Innovations in Medicinal and Pharmaceutical Chemistry for Affordable Healthcare Delivery” Distinguished President and members of the Chemical Society of Nigeria,Esteemed scientists, researchers, academia, […]
Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group
Inauguration Address by Prof. Adeyeye C M,Director General NAFDAC Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group 9th September, 2026. It is with great pleasure that I welcome you to this inauguration today, as we formally receive six hundred pharmacists into voluntary service. These six hundred qualified, service-ready pharmacists are drawn from all thirty-six states […]
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria
The National Agency for Food and Drug Administration and Control (NAFDAC), in collaboration with the National Health Research Ethics Committee (NHREC), announces new dates for the NAFDAC Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria. The training was earlier postponed from its originally announced maiden date; it will now hold from Monday, 5th October […]
Public Alert No. 043/2026-NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist Pending Regulatory Investigation
The National Agency for Food and Drug Administration and Control (NAFDAC) wishes to inform healthcare professionals, distributors, wholesalers, retailers, Patent and Proprietary Medicine Vendors (PPMVs), healthcare institutions, and the general public that products marketed by Mofus Nigeria Ltd have been placed on the NAFDAC Watchlist pending the outcome of an ongoing regulatory investigation. The decision […]
Public Alert No. 042/2026-Alert on the Seizure of Suspected Substandard and Falsified BPPL Artemether/Lumefantrine 80mg/480mg
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare providers, importers, distributors, retailers, Patent and Proprietary Medicine Vendors (PPMVs), and the general public of the seizure of a suspected Substandard and Falsified (SF) antimalarial medicine, Artemether/Lumefantrine 80mg/480mg, purportedly manufactured by Bandaram Pharma Packleh Ltd (BPPL), India. The product was intercepted […]
Public Alert No. 041/2026 – Alert on Suspected Counterfeit ORACIRE+ Toothpaste
The National Agency for Food and Drug Administration and Control (NAFDAC) is informing the public of the circulation of a suspected counterfeit toothpaste product, ORACIRE+ TOOTHPASTE, which is being distributed in Nigeria under the guise of the registered ORACARE+ Toothpaste. This follows a formal complaint and a market intelligence report regarding the widespread distribution of […]
Public Alert No: 039/2026 – Alert on the Risk of Drug Poisoning Associated with Concurrent Use of Gabapentinoids and Other Medicines
The National Agency for Food and Drug Administration and Control (NAFDAC) is informing healthcare professionals and the public of a report received concerning emerging evidence showing an increased risk of drug poisoning when gabapentinoids (gabapentin and pregabalin) are used together with certain medicines, particularly opioids and benzodiazepines. A study conducted by researchers at University College […]
Public Alert No. 038/2026 – Alert on Adulterated and Substandard Medicines- NITRAS, KADIN 2, ACEFYL and LORATADINE 24 Recalled by the Drug Regulatory Authority of Pakistan (DRAP)
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare professionals, importers, distributors, retailers, and the public that the Drug Regulatory Authority of Pakistan (DRAP) has recalled specific batches of adulterated and substandard medicines (Nitras, Kadin 2, Acefyl and Loratadine 24) due to quality defects, contamination concerns, and failure to meet […]